MiraQ for assessing graft flow during coronary artery bypass graft surgery

1 Recommendations

Why the committee made these recommendations

Clinical evidence shows that the MiraQ system is effective for assessing coronary artery bypass grafts and allows for grafts to be revised during surgery. This may reduce the frequency of graft occlusion and may reduce perioperative morbidity and mortality.

The MiraQ system can lead to an estimated cost saving of £80.27 per person compared with clinical assessment. [2022]